214 related articles for article (PubMed ID: 29749374)
1. MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy.
Ren WW; Li DD; Chen X; Li XL; He YP; Guo LH; Liu LN; Sun LP; Zhang XP
Cell Death Dis; 2018 May; 9(5):547. PubMed ID: 29749374
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
4. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.
Luo C; Yin D; Zhan H; Borjigin U; Li C; Zhou Z; Hu Z; Wang P; Sun Q; Fan J; Zhou J; Wang X; Zhou S; Huang X
Cell Death Dis; 2018 May; 9(5):535. PubMed ID: 29749382
[TBL] [Abstract][Full Text] [Related]
5. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3).
Zhang LY; Liu M; Li X; Tang H
J Biol Chem; 2013 Feb; 288(6):4035-47. PubMed ID: 23212913
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.
Que KT; Zhou Y; You Y; Zhang Z; Zhao XP; Gong JP; Liu ZJ
J Exp Clin Cancer Res; 2018 Nov; 37(1):268. PubMed ID: 30400960
[TBL] [Abstract][Full Text] [Related]
7. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.
Kan H; Guo W; Huang Y; Liu D
FEBS Lett; 2015 Jan; 589(1):102-9. PubMed ID: 25436421
[TBL] [Abstract][Full Text] [Related]
9. microRNA-148a-3p enhances the effects of sevoflurane on hepatocellular carcinoma cell progression via ROCK1 repression.
Sun Y; Liu L; Xing W; Sun H
Cell Signal; 2021 Jul; 83():109982. PubMed ID: 33741494
[TBL] [Abstract][Full Text] [Related]
10. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
11. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
12. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
Cui X; Li Q; He Y
Mol Cell Biochem; 2017 Jan; 424(1-2):195-201. PubMed ID: 27822662
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
[TBL] [Abstract][Full Text] [Related]
14. RNA m
Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
[TBL] [Abstract][Full Text] [Related]
16. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
Tang SJ; Yang JB
Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
[TBL] [Abstract][Full Text] [Related]
18. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
Jin F; Wang Y; Li M; Zhu Y; Liang H; Wang C; Wang F; Zhang CY; Zen K; Li L
Cell Death Dis; 2017 Jan; 8(1):e2540. PubMed ID: 28079894
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II.
Jiang JX; Gao S; Pan YZ; Yu C; Sun CY
Mol Med Rep; 2014 Aug; 10(2):995-1002. PubMed ID: 24865963
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
